Phase III double-blind placebo-controlled prospective randomized comparison of adjuvant therapy with tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with involved axillary lymph nodes and positive receptors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fenretinide (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Therapeutic Use
- 22 Sep 2012 Status changed from completed to discontinued.
- 05 Jan 2012 Biomarkers information updated
- 05 Mar 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.